National Bank of Canada’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.09M	Sell	17,934 -9,212	-34%	-$1.71M	﹤0.01%	979
2025 Q4	$5.42M	Sell	27,146 -919,623	-97%	-$167M	0.01%	859
2025 Q3	$148M	Buy	946,769 +511,901	+118%	+$81.3M	0.17%	126
2025 Q2	$66M	Buy	434,868 +400,881	+1,180%	+$53.5M	0.07%	248
2025 Q1	$5.12M	Buy	33,987 +10,132	+42%	+$1.7M	0.01%	891
2024 Q4	$4.4M	Buy	23,855 +2,639	+12%	+$508K	0.01%	1004
2024 Q3	$4.18M	Buy	21,216 +6,627	+45%	+$1.38M	0.01%	875
2024 Q2	$2.96M	Sell	14,589 -28,089	-66%	-$6.36M	﹤0.01%	863
2024 Q1	$9.74M	Sell	42,678 -61,096	-59%	-$14.6M	0.02%	621
2023 Q4	$23.4M	Sell	103,774 -18,681	-15%	-$3.67M	0.04%	365
2023 Q3	$23.5M	Buy	122,455 +41,662	+52%	+$8.55M	0.04%	379
2023 Q2	$16.9M	Sell	80,793 -7,859	-9%	-$1.56M	0.03%	405
2023 Q1	$17.8M	Sell	88,652 -13,711	-13%	-$3.11M	0.05%	300
2022 Q4	$22.3M	Buy	102,363 +51,321	+101%	+$11.2M	0.06%	264
2022 Q3	$10.4M	Buy	51,042 +3,070	+6%	+$663K	0.06%	357
2022 Q2	$10.5M	Buy	47,972 +1,487	+3%	+$363K	0.06%	379
2022 Q1	$13.8M	Buy	46,485 +44,519	+2,264%	+$13.7M	0.05%	384
2021 Q4	$688K	Buy	+1,966	New	+$764K	﹤0.01%	1162